BG106734A - Пиразоло [1, 5-d] [1,2,4] триазини за усилване накогнитивната функция - Google Patents
Пиразоло [1, 5-d] [1,2,4] триазини за усилване накогнитивната функцияInfo
- Publication number
- BG106734A BG106734A BG106734A BG10673402A BG106734A BG 106734 A BG106734 A BG 106734A BG 106734 A BG106734 A BG 106734A BG 10673402 A BG10673402 A BG 10673402A BG 106734 A BG106734 A BG 106734A
- Authority
- BG
- Bulgaria
- Prior art keywords
- optionally substituted
- heteroaromatic ring
- alkyl
- compounds
- membered heteroaromatic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- Hospice & Palliative Care (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Psychiatry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Abstract
Изобретението се отнася до съединения или до техни соли с формула, в която R1 означава халоген или С1-6 алкил, С3-7 циклоалкил, С4-7 циклоалкенил, С6-8 бициклоалкил, С6-10 арил, С3-7 хетероциклоалкил, хетероарил, или ди(С1-6)алкиламино, като всяка от тези групи може да е по избор заместена; L е О, S или NRn, където Rn е Н, С1-6 алкил или С3-6 циклоалкилалкил; W е С1-6 алкил, С2-6 алкенил или С2-6алкинил, заместени по избор; Х е NR4R5 или пет- или шестчленен хетероароматен пръстен, като пет- илишестчленният хетероароматен пръстен по избор е кондензиран към бензенов или пиридинов пръстен и хетероароматният пръстен е заместен по избор; Y е по избор разклонен С1-4 алкилен, заместен по избор с оксогрупа, или Y е група (СН2)jO, където кислородният атом е най-близкият до групата Х, j има стойност 2, 3 или 4; Z означава пет- или шестчленен хетероароматен пръстен, като който и да е от тези пръстени може да е заместен по избор. Изобретението сеотнася и до фармацевтични състави, които съдържатсъединенията, до използването им в методи за лечение и в производството на лекарства за усилване накогнитивната способност, по-специално при лечениена болестта на Алцхаймер, както и до съответнитеметоди за лечение. Съединенията са лиганди и инверсни агонисти на GABAA алфа 5 рецепторен подтип.
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9927874.9A GB9927874D0 (en) | 1999-11-25 | 1999-11-25 | Therapeutic agents |
| GB0009602A GB0009602D0 (en) | 2000-04-18 | 2000-04-18 | Therapeutic agents |
| GB0018651A GB0018651D0 (en) | 2000-07-28 | 2000-07-28 | Therapeutic agents |
| PCT/GB2000/004450 WO2001038331A2 (en) | 1999-11-25 | 2000-11-22 | Pyrazolo[1,5-d][1,2,4]triazines for enhancing cognition |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BG106734A true BG106734A (bg) | 2003-02-28 |
Family
ID=27255677
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BG106734A BG106734A (bg) | 1999-11-25 | 2002-05-22 | Пиразоло [1, 5-d] [1,2,4] триазини за усилване накогнитивната функция |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US6355638B1 (bg) |
| EP (1) | EP1235829A2 (bg) |
| JP (1) | JP2003514909A (bg) |
| KR (1) | KR20020053091A (bg) |
| CN (1) | CN1391574A (bg) |
| AU (1) | AU1533001A (bg) |
| BG (1) | BG106734A (bg) |
| BR (1) | BR0015126A (bg) |
| CA (1) | CA2391103A1 (bg) |
| CZ (1) | CZ20021813A3 (bg) |
| EA (1) | EA200200599A1 (bg) |
| EE (1) | EE200200260A (bg) |
| HK (1) | HK1046406A1 (bg) |
| HU (1) | HUP0203579A3 (bg) |
| IL (1) | IL149051A0 (bg) |
| MX (1) | MXPA02005233A (bg) |
| NO (1) | NO20022456D0 (bg) |
| PL (1) | PL355637A1 (bg) |
| SK (1) | SK8952002A3 (bg) |
| WO (1) | WO2001038331A2 (bg) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0128499D0 (en) * | 2001-11-28 | 2002-01-23 | Merck Sharp & Dohme | Therapeutic agents |
| EP2298296A1 (en) | 2009-08-25 | 2011-03-23 | CNRS Centre National De La Recherche Scientifique | Composition and method for treating cognitive impairments in down syndrome subjects |
| NZ705135A (en) * | 2010-05-26 | 2017-10-27 | Sunovion Pharmaceuticals Inc | Heteroaryl compounds and methods of use thereof |
| US20150374705A1 (en) * | 2012-02-14 | 2015-12-31 | Shanghai Institues for Biological Sciences | Substances for treatment or relief of pain |
| CN107344938B (zh) * | 2016-05-06 | 2022-05-06 | 上海赛默罗生物科技有限公司 | 吡唑-三嗪类衍生物、其制备方法、药物组合物和用途 |
| CN107344936B (zh) * | 2016-05-06 | 2022-06-03 | 上海赛默罗生物科技有限公司 | 三唑哒嗪类衍生物、其制备方法、药物组合物和用途 |
| CN114258390A (zh) * | 2019-06-19 | 2022-03-29 | 生物马林药物股份有限公司 | 用于疾病治疗的乙醇酸氧化酶抑制剂 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL331072A1 (en) * | 1996-07-25 | 1999-06-21 | Merck Sharp & Dohme | Substututed derivatives of triazolo-pyrydazine as ligands for gaba receptors |
| GB9715977D0 (en) * | 1997-07-29 | 1997-10-01 | Merck Sharp & Dohme | Therapeutic agents |
| AU746866B2 (en) * | 1998-01-14 | 2002-05-02 | Merck Sharp & Dohme Limited | Triazolo-pyridazine derivatives as ligands for GABA receptors |
| GB9806102D0 (en) * | 1998-03-20 | 1998-05-20 | Merck Sharp & Dohme | Therapeutic agents |
| US6479506B1 (en) * | 1998-06-16 | 2002-11-12 | Merck Sharp & Dohme Ltd. | Triazolo-pyridine derivatives as ligands for GABA receptors |
| CA2346289A1 (en) * | 1998-10-16 | 2000-04-27 | Merck Sharp & Dohme Limited | Pyrazolo-triazine derivatives as ligands for gaba receptors |
-
2000
- 2000-11-21 US US09/717,423 patent/US6355638B1/en not_active Expired - Lifetime
- 2000-11-22 EA EA200200599A patent/EA200200599A1/ru unknown
- 2000-11-22 CZ CZ20021813A patent/CZ20021813A3/cs unknown
- 2000-11-22 PL PL00355637A patent/PL355637A1/xx not_active Application Discontinuation
- 2000-11-22 WO PCT/GB2000/004450 patent/WO2001038331A2/en not_active Application Discontinuation
- 2000-11-22 IL IL14905100A patent/IL149051A0/xx unknown
- 2000-11-22 SK SK895-2002A patent/SK8952002A3/sk unknown
- 2000-11-22 JP JP2001540094A patent/JP2003514909A/ja not_active Withdrawn
- 2000-11-22 KR KR1020027006672A patent/KR20020053091A/ko not_active Application Discontinuation
- 2000-11-22 BR BR0015126-2A patent/BR0015126A/pt not_active Application Discontinuation
- 2000-11-22 EP EP00977692A patent/EP1235829A2/en not_active Withdrawn
- 2000-11-22 MX MXPA02005233A patent/MXPA02005233A/es not_active Application Discontinuation
- 2000-11-22 HU HU0203579A patent/HUP0203579A3/hu unknown
- 2000-11-22 AU AU15330/01A patent/AU1533001A/en not_active Abandoned
- 2000-11-22 CN CN00816013A patent/CN1391574A/zh active Pending
- 2000-11-22 CA CA002391103A patent/CA2391103A1/en not_active Abandoned
- 2000-11-22 EE EEP200200260A patent/EE200200260A/xx unknown
-
2002
- 2002-05-22 BG BG106734A patent/BG106734A/bg unknown
- 2002-05-24 NO NO20022456A patent/NO20022456D0/no not_active Application Discontinuation
- 2002-10-29 HK HK02107821.8A patent/HK1046406A1/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NO20022456L (no) | 2002-05-24 |
| JP2003514909A (ja) | 2003-04-22 |
| MXPA02005233A (es) | 2002-11-07 |
| CN1391574A (zh) | 2003-01-15 |
| SK8952002A3 (en) | 2002-10-08 |
| BR0015126A (pt) | 2002-07-02 |
| CZ20021813A3 (cs) | 2002-08-14 |
| EE200200260A (et) | 2003-06-16 |
| EP1235829A2 (en) | 2002-09-04 |
| AU1533001A (en) | 2001-06-04 |
| WO2001038331A3 (en) | 2001-11-08 |
| CA2391103A1 (en) | 2001-05-31 |
| IL149051A0 (en) | 2002-11-10 |
| HUP0203579A3 (en) | 2003-07-28 |
| PL355637A1 (en) | 2004-05-04 |
| NO20022456D0 (no) | 2002-05-24 |
| HK1046406A1 (zh) | 2003-01-10 |
| HUP0203579A2 (hu) | 2003-03-28 |
| WO2001038331A2 (en) | 2001-05-31 |
| EA200200599A1 (ru) | 2002-12-26 |
| KR20020053091A (ko) | 2002-07-04 |
| US6355638B1 (en) | 2002-03-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6437544B2 (ja) | 置換キナゾリン−４−オン誘導体 | |
| JP5502731B2 (ja) | 新しい抗微生物化合物、それらの合成および哺乳類の感染症の処置のためのそれらの使用 | |
| JP2004532233A (ja) | Ｐｄｅ７及びｐｄｅ４の２元阻害剤 | |
| JP2013541495A5 (bg) | ||
| RU2008148900A (ru) | Амино-имидазолоны и их применение в качестве лекарственного средства для лечения когнитивного нарушения, болезни альцгеймера, нейродегенерации и деменции | |
| HUP0105081A2 (hu) | Triazolo[4,5-d]pirimidin-származékok, eljárás előállításukra, alkalmazásuk és az ezeket tartalmazó gyógyszerkészítmények | |
| AR022848A1 (es) | Compuestos de imidazol sustituido con un anillo heterociclico de seis o siete miembros que contiene dos atomos de nitrogeno | |
| AR056470A1 (es) | Sulfonamidos n- ciclicos puenteados inhibidores de gamma secretasa | |
| JP7316672B2 (ja) | 細菌感染を予防及び処置するためのピリミジン誘導体 | |
| TW201139449A (en) | Sulfonamide derivatives as MEK inhibitors | |
| JP2008515979A (ja) | フラザノ‘３，４−ビピラジン（ｂｉｐｙｒａｚｉｎｅ）及び抗腫瘍剤としてのその使用 | |
| TW200630371A (en) | Halogen substituted benzodiazepine derivatives | |
| DK2483274T3 (en) | Antimalarials, which are inhibitors of dihydroorotate | |
| BG106734A (bg) | Пиразоло [1, 5-d] [1,2,4] триазини за усилване накогнитивната функция | |
| RU2010135253A (ru) | Агонисты мускариновых рецепторов, композиции и способы лечения с их применением и способы их получения 177 | |
| KR20180043289A (ko) | 화합물 | |
| ATE106400T1 (de) | Substituierte 3h-indole, verfahren zu ihrer herstellung sowie arzneimittel. | |
| JP2009538909A5 (bg) | ||
| US9694017B2 (en) | Substituted triazolobenzodiazepines | |
| AU2012207393A1 (en) | Quinazolinone inhibitors of dynein | |
| TW201536795A (zh) | 作為細胞保護劑用之芳基噻嗪化合物 | |
| ATE5407T1 (de) | 2-substituierte triazolo(4,3-a)pyridin-3(2h)-one, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen zur behandlung von depressionen. | |
| ATE5193T1 (de) | Triazolo (4,3-a)pyridin-3-(2h)-one, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen. | |
| KR102678805B1 (ko) | 박테리아 감염의 예방 및 치료를 위한 피리미딘 유도체 | |
| KR910020018A (ko) | 피리도[3, 4-b] 피롤로[1, 2-e][1, 4, 5]옥사디아제핀 및 이의 관련 동족체 이의 제조방법 및 약제로서의 이의 용도 |